Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up
- Conditions
- Multiple Sclerosis
- Registration Number
- NCT00289159
- Lead Sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Brief Summary
To determine wether multimodal MRI (conventinal T1 and T2 sequences, diffusion, magnetization transfer, spectroscopy) is reproducible; to follow up a cohort of patients with early remmittent MS after treatment with interferon.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- MS patients according to Poser's criteria
- Remitting evolution (less than two years of evolution)
- Aged 18-50
- Immunomodulatory treatment indicated
Exclusion Criteria
- Unable to perform MRI
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method